Carterra LSA
Disruptive Technology for mAb Screening and Characterization.
Carterra LSA
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Great high throughput label free binding assay instrument.
Binding small molecules in lysates and biological samples using 96 print head technology
Carterra LSA helped us to determine the binding of small molecules in lysates and biological samples using 96 print head technology. Its epitope binning technology is unique as it helps to bin libraries of molecules in short period of time compared to BIACORE 8K. The after sales services from field application scientist is great as well!
Review Date: 28 Jan 2020 | Carterra
Carterra® is a leading provider of innovative technologies designed to accelerate the discovery of novel therapeutic candidates. Carterra’s high throughput LSA™ instrument for monoclonal antibody (mAb) screening and characterization combines patented microfluidics technology with real-time High Throughput Surface Plasmon Resonance (HT-SPR) and industry leading Kinetic and Epitope analysis and visualization software, delivering up to 100 times the throughput in 10% of the time while using only 1% of the sample compared to existing platforms. The LSA provides customers with screening and characterization throughput and functionality that matches the output from state-of-the-art antibody expression platforms. This enables all antibodies to be rapidly and comprehensively screened early in the discovery process so that unique epitopes and potential novel therapeutic candidates can be identified, while expanding and enhancing IP coverage. The Carterra LSA condenses months of work into a few days.
